ES2555215T3 - Composiciones de reactivo de bajo contenido salino total y sistemas para biosensores - Google Patents

Composiciones de reactivo de bajo contenido salino total y sistemas para biosensores Download PDF

Info

Publication number: ES2555215T3
Authority: ES; Spain
Prior art keywords: per; nmol; reagent composition; maximum; reagent
Prior art date: 2008-12-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES09775437.8T

Other languages

English (en)

Spanish (es)

Inventor

Amy H. Chu

Huan-Ping Wu

Boru Zhu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Healthcare LLC

Original Assignee

Bayer Healthcare LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-08

Filing date

2009-12-07

Publication date

2015-12-29

2009-12-07 Application filed by Bayer Healthcare LLC filed Critical Bayer Healthcare LLC

2015-12-29 Application granted granted Critical

2015-12-29 Publication of ES2555215T3 publication Critical patent/ES2555215T3/es

Status Active legal-status Critical Current

2029-12-07 Anticipated expiration legal-status Critical

Links

239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 273
239000000203 mixture Substances 0.000 title claims abstract description 259
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title description 46
239000011780 sodium chloride Substances 0.000 title description 46
238000012360 testing method Methods 0.000 claims abstract description 117
239000012491 analyte Substances 0.000 claims abstract description 90
239000004020 conductor Substances 0.000 claims abstract description 54
239000000337 buffer salt Substances 0.000 claims abstract description 39
239000011230 binding agent Substances 0.000 claims abstract description 37
229910052723 transition metal Inorganic materials 0.000 claims abstract description 31
239000002736 nonionic surfactant Substances 0.000 claims abstract description 28
230000002255 enzymatic effect Effects 0.000 claims abstract description 25
229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 20
150000003624 transition metals Chemical class 0.000 claims abstract description 20
102000004190 Enzymes Human genes 0.000 claims description 38
108090000790 Enzymes Proteins 0.000 claims description 38
239000003945 anionic surfactant Substances 0.000 claims description 20
-1 transition metal salt Chemical class 0.000 claims description 16
239000004094 surface-active agent Substances 0.000 claims description 15
235000019846 buffering salt Nutrition 0.000 claims description 10
239000002563 ionic surfactant Substances 0.000 claims description 5
238000004891 communication Methods 0.000 claims description 4
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
235000019800 disodium phosphate Nutrition 0.000 claims description 3
239000000523 sample Substances 0.000 description 131
239000012530 fluid Substances 0.000 description 43
238000004458 analytical method Methods 0.000 description 39
229940088598 enzyme Drugs 0.000 description 38
238000005534 hematocrit Methods 0.000 description 28
230000005284 excitation Effects 0.000 description 27
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 19
239000008103 glucose Substances 0.000 description 19
238000000034 method Methods 0.000 description 18
150000003839 salts Chemical class 0.000 description 18
239000000463 material Substances 0.000 description 16
230000007423 decrease Effects 0.000 description 15
238000000151 deposition Methods 0.000 description 15
238000012546 transfer Methods 0.000 description 15
210000004369 blood Anatomy 0.000 description 14
239000008280 blood Substances 0.000 description 14
230000008021 deposition Effects 0.000 description 14
238000005259 measurement Methods 0.000 description 14
239000013060 biological fluid Substances 0.000 description 12
239000010410 layer Substances 0.000 description 12
230000000694 effects Effects 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
238000003556 assay Methods 0.000 description 10
239000002245 particle Substances 0.000 description 9
239000007788 liquid Substances 0.000 description 8
238000006479 redox reaction Methods 0.000 description 8
230000009467 reduction Effects 0.000 description 8
238000006722 reduction reaction Methods 0.000 description 8
230000004044 response Effects 0.000 description 8
230000027756 respiratory electron transport chain Effects 0.000 description 7
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
230000002596 correlated effect Effects 0.000 description 6
230000006872 improvement Effects 0.000 description 6
239000004615 ingredient Substances 0.000 description 6
229910052751 metal Inorganic materials 0.000 description 6
239000002184 metal Substances 0.000 description 6
230000003647 oxidation Effects 0.000 description 6
238000007254 oxidation reaction Methods 0.000 description 6
239000000126 substance Substances 0.000 description 6
229910019142 PO4 Inorganic materials 0.000 description 5
OATNQHYJXLHTEW-UHFFFAOYSA-N benzene-1,4-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(S(O)(=O)=O)C=C1 OATNQHYJXLHTEW-UHFFFAOYSA-N 0.000 description 5
235000021317 phosphate Nutrition 0.000 description 5
239000000725 suspension Substances 0.000 description 5
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
108090000854 Oxidoreductases Proteins 0.000 description 4
102000004316 Oxidoreductases Human genes 0.000 description 4
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
239000002585 base Substances 0.000 description 4
239000000872 buffer Substances 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
SBWGZAXBCCNRTM-CTHBEMJXSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]octanamide Chemical compound CCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SBWGZAXBCCNRTM-CTHBEMJXSA-N 0.000 description 4
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
239000012429 reaction media Substances 0.000 description 4
229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
ILBONRFSLATCRE-UHFFFAOYSA-N Phosfolan Chemical compound CCOP(=O)(OCC)N=C1SCCS1 ILBONRFSLATCRE-UHFFFAOYSA-N 0.000 description 3
229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
239000004372 Polyvinyl alcohol Substances 0.000 description 3
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
238000001035 drying Methods 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
229920000847 nonoxynol Polymers 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
229920002451 polyvinyl alcohol Polymers 0.000 description 3
239000002344 surface layer Substances 0.000 description 3
229940116269 uric acid Drugs 0.000 description 3
AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 description 2
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
101710088194 Dehydrogenase Proteins 0.000 description 2
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
230000008901 benefit Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000012472 biological sample Substances 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
239000008112 carboxymethyl-cellulose Substances 0.000 description 2
229940105329 carboxymethylcellulose Drugs 0.000 description 2
230000008859 change Effects 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
238000012937 correction Methods 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
239000010931 gold Substances 0.000 description 2
239000001863 hydroxypropyl cellulose Substances 0.000 description 2
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
239000012535 impurity Substances 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
229950006238 nadide Drugs 0.000 description 2
229910052763 palladium Inorganic materials 0.000 description 2
150000002990 phenothiazines Chemical class 0.000 description 2
150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
229910052697 platinum Inorganic materials 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
230000008569 process Effects 0.000 description 2
229940104256 sodium taurate Drugs 0.000 description 2
GWLWWNLFFNJPDP-UHFFFAOYSA-M sodium;2-aminoethanesulfonate Chemical compound [Na+].NCCS([O-])(=O)=O GWLWWNLFFNJPDP-UHFFFAOYSA-M 0.000 description 2
239000007787 solid Substances 0.000 description 2
150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
230000008961 swelling Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
230000007704 transition Effects 0.000 description 2
238000011282 treatment Methods 0.000 description 2
150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
NECRQCBKTGZNMH-UHFFFAOYSA-N 3,5-dimethylhex-1-yn-3-ol Chemical compound CC(C)CC(C)(O)C#C NECRQCBKTGZNMH-UHFFFAOYSA-N 0.000 description 1
BKIKFYRTTUYTJZ-UHFFFAOYSA-N 7-hydroxy-9,9-dimethylacridin-2-one Chemical compound C1=C(O)C=C2C(C)(C)C3=CC(=O)C=CC3=NC2=C1 BKIKFYRTTUYTJZ-UHFFFAOYSA-N 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 description 1
108010025188 Alcohol oxidase Proteins 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
108010006591 Apoenzymes Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical group OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
229920000896 Ethulose Polymers 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
102000002794 Glucosephosphate Dehydrogenase Human genes 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
102000013460 Malate Dehydrogenase Human genes 0.000 description 1
108010026217 Malate Dehydrogenase Proteins 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
229920001730 Moisture cure polyurethane Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
229910021607 Silver chloride Inorganic materials 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
238000013459 approach Methods 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000005229 chemical vapour deposition Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
229920001940 conductive polymer Polymers 0.000 description 1
239000000470 constituent Substances 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
239000003989 dielectric material Substances 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000000840 electrochemical analysis Methods 0.000 description 1
238000000835 electrochemical detection Methods 0.000 description 1
238000003487 electrochemical reaction Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
235000021588 free fatty acids Nutrition 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
108010051015 glutathione-independent formaldehyde dehydrogenase Proteins 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
210000002977 intracellular fluid Anatomy 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical class O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
239000000178 monomer Substances 0.000 description 1
125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
UMWKZHPREXJQGR-UHFFFAOYSA-N n-methyl-n-(2,3,4,5,6-pentahydroxyhexyl)decanamide Chemical compound CCCCCCCCCC(=O)N(C)CC(O)C(O)C(O)C(O)CO UMWKZHPREXJQGR-UHFFFAOYSA-N 0.000 description 1
GCRLIVCNZWDCDE-UHFFFAOYSA-N n-methyl-n-(2,3,4,5,6-pentahydroxyhexyl)nonanamide Chemical compound CCCCCCCCC(=O)N(C)CC(O)C(O)C(O)C(O)CO GCRLIVCNZWDCDE-UHFFFAOYSA-N 0.000 description 1
VHYYJWLKCODCNM-OIMNJJJWSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]heptanamide Chemical compound CCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO VHYYJWLKCODCNM-OIMNJJJWSA-N 0.000 description 1
BRTPYBXQVFNPCB-UHFFFAOYSA-N n-phenyl-3h-phenoxazin-3-amine Chemical class C1=CC2=NC3=CC=CC=C3OC2=CC1NC1=CC=CC=C1 BRTPYBXQVFNPCB-UHFFFAOYSA-N 0.000 description 1
DLZPPUIHGWXDNJ-UHFFFAOYSA-N n-phenylphenothiazin-3-imine Chemical class C1=CC=CC=C1N=C1C=C2SC3=CC=CC=C3N=C2C=C1 DLZPPUIHGWXDNJ-UHFFFAOYSA-N 0.000 description 1
LJXXBBCNKKOAHS-UHFFFAOYSA-N n-phenylphenoxazin-3-imine Chemical class C1=CC=CC=C1N=C1C=C2OC3=CC=CC=C3N=C2C=C1 LJXXBBCNKKOAHS-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
125000006353 oxyethylene group Chemical group 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
229950000688 phenothiazine Drugs 0.000 description 1
125000001644 phenoxazinyl group Chemical class C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
150000003014 phosphoric acid esters Chemical class 0.000 description 1
XENHFSZRMFXQBS-UHFFFAOYSA-N phosphoric acid;pyridine-3-carboxamide Chemical compound OP(O)(O)=O.NC(=O)C1=CC=CN=C1 XENHFSZRMFXQBS-UHFFFAOYSA-N 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
229920001308 poly(aminoacid) Polymers 0.000 description 1
229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
229960002796 polystyrene sulfonate Drugs 0.000 description 1
239000011970 polystyrene sulfonate Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 1
238000011002 quantification Methods 0.000 description 1
150000004053 quinones Chemical class 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 description 1
BPEVHDGLPIIAGH-UHFFFAOYSA-N ruthenium(3+) Chemical compound [Ru+3] BPEVHDGLPIIAGH-UHFFFAOYSA-N 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
239000004065 semiconductor Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
LGORLCOUTMVEAC-UHFFFAOYSA-M sodium;2-nonylphenolate Chemical compound [Na+].CCCCCCCCCC1=CC=CC=C1[O-] LGORLCOUTMVEAC-UHFFFAOYSA-M 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
150000003871 sulfonates Chemical class 0.000 description 1
229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 description 1
125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
210000002700 urine Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/004—Enzyme electrodes mediator-assisted
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Analytical Chemistry (AREA)
Wood Science & Technology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

ES09775437.8T 2008-12-08 2009-12-07 Composiciones de reactivo de bajo contenido salino total y sistemas para biosensores Active ES2555215T3 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20124208P	2008-12-08	2008-12-08
US201242P		2008-12-08
PCT/US2009/066963 WO2010077598A1 (en)	2008-12-08	2009-12-07	Low total salt reagent compositions and systems for biosensors

Publications (1)

Publication Number	Publication Date
ES2555215T3 true ES2555215T3 (es)	2015-12-29

Family

ID=41800700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES09775437.8T Active ES2555215T3 (es)	2008-12-08	2009-12-07	Composiciones de reactivo de bajo contenido salino total y sistemas para biosensores

Country Status (14)

Country	Link
US (1)	US8871069B2 (pt)
EP (1)	EP2373805B1 (pt)
JP (2)	JP5773883B2 (pt)
CN (1)	CN102227505B (pt)
BR (1)	BRPI0923340A2 (pt)
CA (1)	CA2742377C (pt)
DK (1)	DK2373805T3 (pt)
ES (1)	ES2555215T3 (pt)
HR (1)	HRP20151237T1 (pt)
MX (1)	MX2011006046A (pt)
PL (1)	PL2373805T3 (pt)
PT (1)	PT2373805E (pt)
RU (1)	RU2546862C2 (pt)
WO (1)	WO2010077598A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9233788B2 (en)	2010-01-22	2016-01-12	Bayer Healthcare Llc	Biosensor desiccant system having enhanced measurement performance
TWI565943B (zh) *	2011-07-22	2017-01-11	拜耳保健公司	具有增進測量性能之生物感測器乾燥劑系統
CA2949909C (en)	2013-03-15	2019-10-01	F. Hoffmann-La Roche Ag	Methods of scaling data used to construct biosensor algorithms as well as devices, apparatuses and systems incorporating the same
PL3117006T3 (pl) *	2014-03-13	2018-12-31	PAL Finland Oy	Pasek testowy i urządzenie do mierzenia zawartości alkoholu we krwi, oraz sposób do mierzenia zawartości alkoholu we krwi
GB2531728A (en) *	2014-10-27	2016-05-04	Cilag Gmbh Int	Method for determining diffusion
US11366046B2 (en)	2017-02-10	2022-06-21	Hewlett-Packard Development Company, L.P.	Determine viscosity of fluids using a capillary channel
US20210076991A1 (en) *	2018-01-16	2021-03-18	The Regents Of The University Of California	In-situ sweat rate monitoring for normalization of sweat analyte concentrations
RU197895U1 (ru) *	2020-02-05	2020-06-04	Общество с ограниченной ответственностью "МедТехПродукт"	Электрохимический биосенсор для определения концентрации глюкозы в крови
RU209089U1 (ru) *	2021-10-22	2022-02-01	Кирилл Владимирович Романенко	Электрохимический биосенсор для определения концентрации глюкозы в крови

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4713165A (en) *	1986-07-02	1987-12-15	Ilex Corporation	Sensor having ion-selective electrodes
DE68924026T3 (de)	1988-03-31	2008-01-10	Matsushita Electric Industrial Co., Ltd., Kadoma	Biosensor und dessen herstellung.
US5508171A (en)	1989-12-15	1996-04-16	Boehringer Mannheim Corporation	Assay method with enzyme electrode system
CA2069946C (en) *	1989-12-15	1999-01-26	Klaus H. Pollmann	Redox mediator reagent and biosensor
US5393615A (en)	1994-02-03	1995-02-28	Miles Inc.	Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
US5498542A (en)	1994-09-29	1996-03-12	Bayer Corporation	Electrode mediators for regeneration of NADH and NADPH
US6153069A (en)	1995-02-09	2000-11-28	Tall Oak Ventures	Apparatus for amperometric Diagnostic analysis
US5520786A (en)	1995-06-06	1996-05-28	Bayer Corporation	Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof
AUPN661995A0 (en) *	1995-11-16	1995-12-07	Memtec America Corporation	Electrochemical cell 2
US5798031A (en)	1997-05-12	1998-08-25	Bayer Corporation	Electrochemical biosensor
JP3260739B2 (ja) *	1997-12-22	2002-02-25	ロシュダイアグノスティックスコーポレーション	生物学的流体の医学的に有意な成分の濃度を測定する装置および方法
AU3849799A (en) *	1998-05-20	1999-12-06	Arkray, Inc.	Method and apparatus for electrochemical measurement using statistical technique
JP2000039416A (ja) *	1998-05-21	2000-02-08	Matsushita Electric Ind Co Ltd	バイオセンサ
US6287451B1 (en) *	1999-06-02	2001-09-11	Handani Winarta	Disposable sensor and method of making
CA2305922C (en)	1999-08-02	2005-09-20	Bayer Corporation	Improved electrochemical sensor design
US7163616B2 (en)	2001-09-14	2007-01-16	Bayer Corporation	Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes
DE10243599A1 (de) *	2002-09-19	2004-04-01	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Messvorrichtung und -verfahren für ein Screening bei auf Elektroden immobilisierten Zellen
KR100785670B1 (ko)	2003-06-20	2007-12-14	에프. 호프만-라 로슈 아게	폭이 좁은 균질한 시약 시트립을 제조하는 방법 및 시약
EP1679508B1 (en) *	2003-10-30	2010-07-21	Arkray, Inc.	Biosensor and method for preparation thereof
JP4449431B2 (ja) *	2003-11-19	2010-04-14	パナソニック株式会社	基質濃度の測定方法
EP3483599A1 (en)	2005-07-20	2019-05-15	Ascensia Diabetes Care Holdings AG	Methods for measuring the concentration of an analyte in solution and for calibrating the measurement as well as handheld devices therefor
CN103048442B (zh)	2005-09-30	2015-04-08	拜尔健康护理有限责任公司	门控伏特安培法
US7955484B2 (en) *	2005-12-14	2011-06-07	Nova Biomedical Corporation	Glucose biosensor and method
RU2455925C2 (ru) *	2006-02-27	2012-07-20	БАЙЕР ХЕЛТКЭА ЭлЭлСи	Определение исследуемого вещества с поправкой на температуру для систем биодатчиков
US8163162B2 (en) *	2006-03-31	2012-04-24	Lifescan, Inc.	Methods and apparatus for analyzing a sample in the presence of interferents
BRPI0717430A2 (pt) *	2006-09-22	2013-11-12	Bayer Healthcare Llc	Sistema de biossensor tendo estabilidade e desempenho de hematócritos maiores
US8163146B2 (en) *	2007-10-12	2012-04-24	Abbott Diabetes Care Inc.	Mediator stabilized reagent compositions for use in biosensor electrodes
EP3369825B1 (en) *	2007-12-10	2021-07-28	Ascensia Diabetes Care Holdings AG	Porous particle reagent compositions and devices for biosensors
RU2706691C2 (ru)	2007-12-10	2019-11-20	Асцензия Диабетс Кэар Холдингс АГ	Способ определения концентрации аналита
EP3187866B1 (en)	2007-12-10	2019-04-17	Ascensia Diabetes Care Holdings AG	Electrochemical test sensor
RU2491549C2 (ru)	2007-12-10	2013-08-27	БАЙЕР ХЕЛТКЭА ЭлЭлСи	Амперометрия со стробированием и быстрым считыванием
US20090145775A1 (en) *	2007-12-10	2009-06-11	Bayer Healthcare Llc	Reagents and methods for detecting analytes
CN102089650B (zh)	2008-07-10	2014-01-29	拜尔健康护理有限责任公司	具有电流分析法及伏安分析法的工作循环的系统及方法
RU2509304C2 (ru)	2008-12-08	2014-03-10	БАЙЕР ХЕЛТКЭА ЭлЭлСи	Биосенсорная система с корректировкой сигнала

2009
- 2009-12-07 RU RU2011128002/10A patent/RU2546862C2/ru not_active IP Right Cessation
- 2009-12-07 WO PCT/US2009/066963 patent/WO2010077598A1/en not_active Ceased
- 2009-12-07 CA CA2742377A patent/CA2742377C/en not_active Expired - Fee Related
- 2009-12-07 MX MX2011006046A patent/MX2011006046A/es active IP Right Grant
- 2009-12-07 HR HRP20151237TT patent/HRP20151237T1/hr unknown
- 2009-12-07 PT PT97754378T patent/PT2373805E/pt unknown
- 2009-12-07 PL PL09775437T patent/PL2373805T3/pl unknown
- 2009-12-07 BR BRPI0923340A patent/BRPI0923340A2/pt not_active Application Discontinuation
- 2009-12-07 DK DK09775437.8T patent/DK2373805T3/en active
- 2009-12-07 ES ES09775437.8T patent/ES2555215T3/es active Active
- 2009-12-07 EP EP09775437.8A patent/EP2373805B1/en active Active
- 2009-12-07 CN CN200980147993.2A patent/CN102227505B/zh active Active
- 2009-12-07 JP JP2011540801A patent/JP5773883B2/ja active Active
2011
- 2011-06-06 US US13/154,088 patent/US8871069B2/en active Active
2014
- 2014-08-01 JP JP2014157974A patent/JP6081414B2/ja active Active

Also Published As

Publication number	Publication date
CA2742377C (en)	2018-05-22
CN102227505B (zh)	2016-05-11
JP5773883B2 (ja)	2015-09-02
PT2373805E (pt)	2015-12-30
BRPI0923340A2 (pt)	2018-05-29
WO2010077598A1 (en)	2010-07-08
EP2373805A1 (en)	2011-10-12
CN102227505A (zh)	2011-10-26
JP2012511159A (ja)	2012-05-17
EP2373805B1 (en)	2015-11-04
RU2011128002A (ru)	2013-01-20
CA2742377A1 (en)	2010-07-08
DK2373805T3 (en)	2015-12-07
MX2011006046A (es)	2011-07-20
PL2373805T3 (pl)	2016-03-31
JP6081414B2 (ja)	2017-02-15
HRP20151237T1 (hr)	2015-12-18
RU2546862C2 (ru)	2015-04-10
US8871069B2 (en)	2014-10-28
US20110297540A1 (en)	2011-12-08
JP2014224828A (ja)	2014-12-04

Publication	Publication Date	Title
AU2006272909B2 (en)	2013-02-07	Gated amperometry
ES2636676T3 (es)	2017-10-06	Método de ensayo de múltiples electrodos
JP6081414B2 (ja)	2017-02-15	バイオセンサのための低全塩試薬組成物およびシステム
ES2664574T3 (es)	2018-04-20	Composiciones reactivas de partículas porosas, dispositivos y métodos para biosensores
JP2014224828A5 (pt)	2016-09-08
AU2014218413B2 (en)	2016-09-15	Gated amperometry
AU2013200069B2 (en)	2014-06-05	Gated amperometry
AU2016213744B2 (en)	2017-11-23	Gated amperometry
HK1229422A1 (en)	2017-11-17	Test sensor for determining the concentration of an analyte in a sample
HK1108815A (en)	2008-05-23	Methods for analyzing a sample in the presence of interferents